Publications

A novel bis-furan scaffold transthyretin stabilization and amyloid inhibition.

Simões CJV, Almeida ZL, Costa D, Jesus CSH, Cardoso AL, Almeida MR, Saraiva MJ, Pinho e Melo TMVD, Brito RMM

Toward the discovery of functional transthyretin amyloid inhibitors: application of virtual screening methods.

Simões CJ, Mukherjee T, Brito RM, Jackson RM

Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.

Rodrigues JR, Simões CJ, Silva CG, Brito RM

A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.

Camacho R, Pereira M, Costa VS, Fonseca NA, Adriano C, Simões CJ, Brito RM

A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.

Faria TQ, Almeida ZL, Cruz PF, Jesus CS, Castanheira P, Brito RM

A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.

Jesus CS, Almeida ZL, Vaz DC, Faria TQ, Brito RM

Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin.

Shnyrov VL, Villar E, Zhadan GG, Sanchez-Ruiz JM, Quintas A, Saraiva MJ, Brito RM

Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.

Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM

The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis.

Quintas A, Saraiva MJ, Brito RM

AT50 Series: 2 - thioxothiazolin - 4 - one derivatives as novel potent transthyretin stabilizers

A.L. Cardoso , B.F.O. Nascimento, Z.L. Almeida, B.L. Victor, C.J.V. Simões, R.M.M. Brito, T.M.V.D Pinho e Melo

Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry, July 2018, Palermo, Italy

Rational design, synthesis and biological evaluation of inhibitors of transthyretin amyloidogenesis: optimization of thiazolidinedione - based derivatives

Z.L. Almeida , C.J.V. Simões, B.F.O . Nascimento, B.L. Víctor; A.L. Cardoso, P.F. Cruz , T.M.V.D. Pinho e Melo , R.M.M. Brito

Italian-Spanish-Portuguese Joint Meeting in Medicinal Chemistry, July 2018, Palermo, Italy

Classification of corneal permeability of drug-like compounds using data mining and machine learning

Meireles J, Simões CJV, Brito RMM

11th International Conference on Chemical Structures, May 2018, Noordwijkerhout, The Netherlands

Lead Optimization of Resilient Second-Generation Transthyretin Stabilizers for Multiple Target-Product Profiles: Where Do We Go From Here?

Simões CJV, Almeida ZL, Cardoso AL, Almeida MR, Beirão J, Pinho e Melo TMVD, Saraiva MJ, Brito RMM

XVIth International Symposium on Amyloidosis, March 2018, Kumamoto, Japan

Targeting transthyretin amyloidosis in the eye with a second-generation stabilizer: AT40X01 displays potent TTR stabilization in the human vitreous.

Bezerra F, Beirão J, Simões CJV, Brito RMM, Saraiva MJ, Almeida MR

XVIth International Symposium on Amyloidosis, March 2018, Kumamoto, Japan

Highly active 2-thioxothiazolidin-4-one derivatives for transthyretin protein stabilization and amyloid fibril inhibition.

Nascimento BFO, Almeida ZL, Simões CJV, Victor BL, Cardoso AL, Brito RMM, Pinho e Melo TMVD

12th National Organic Chemistry Meeting (12ENQO) and the 5th National Medicinal Chemistry Meeting (5ENQT), January 2018, Coimbra, Portugal

Discovery of 2-thioxothiazolidin-4-ones as potent transthyretin stabilizers: a story of pride and prejudice in the quest for a better drug.

Simões CJV, Almeida ZL, Victor BL, Nascimento BFO, Cardoso AL, Pinho e Melo TMVD, Brito RMM

12th National Organic Chemistry Meeting (12ENQO) and the 5th National Medicinal Chemistry Meeting (5ENQT), January 2018, Coimbra, Portugal

Bis-furan derivatives as transthyretin (TTR) stabilizers and amyloid inhibitors for the treatment of Familial Amyloid Polyneuropathy (FAP).

Simões CJV, Almeida ZL, Cardoso AL, Pinho e Melo TMVD, Brito RMM, Costa D

WO/2016/203402

2-Thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof.

Brito RMM, Simões CJV, Pinho e Melo TMVD, Victor BLS, Almeida ZL, Cardoso AL, Nascimento BF, Ferreira MS

WO/2016/080853